Keros Therapeutics Inc (KROS)
52.21
-1.78
(-3.30%)
USD |
NASDAQ |
May 17, 16:00
52.21
0.00 (0.00%)
After-Hours: 19:36
Keros Therapeutics 1 Year Total Returns (Daily): 16.48% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | 16.48% |
May 15, 2024 | 15.88% |
May 14, 2024 | 17.44% |
May 13, 2024 | 20.11% |
May 10, 2024 | 20.55% |
May 09, 2024 | 30.17% |
May 08, 2024 | 35.13% |
May 07, 2024 | 33.00% |
May 06, 2024 | 36.58% |
May 03, 2024 | 33.74% |
May 02, 2024 | 26.97% |
May 01, 2024 | 25.29% |
April 30, 2024 | 27.13% |
April 29, 2024 | 32.16% |
April 26, 2024 | 33.04% |
April 25, 2024 | 23.55% |
April 24, 2024 | 27.30% |
April 23, 2024 | 21.94% |
April 22, 2024 | 23.24% |
April 19, 2024 | 35.53% |
April 18, 2024 | 41.20% |
April 17, 2024 | 45.13% |
April 16, 2024 | 49.52% |
April 15, 2024 | 48.70% |
April 12, 2024 | 57.30% |
Date | Value |
---|---|
April 11, 2024 | 64.72% |
April 10, 2024 | 58.41% |
April 09, 2024 | 58.97% |
April 08, 2024 | 57.42% |
April 05, 2024 | 57.48% |
April 04, 2024 | 47.14% |
April 03, 2024 | 48.51% |
April 02, 2024 | 49.93% |
April 01, 2024 | 56.65% |
March 28, 2024 | 59.29% |
March 27, 2024 | 54.95% |
March 26, 2024 | 59.53% |
March 25, 2024 | 59.89% |
March 22, 2024 | 55.65% |
March 21, 2024 | 56.72% |
March 20, 2024 | 54.18% |
March 19, 2024 | 50.78% |
March 18, 2024 | 49.98% |
March 15, 2024 | 54.69% |
March 14, 2024 | 43.62% |
March 13, 2024 | 50.59% |
March 12, 2024 | 52.59% |
March 11, 2024 | 49.79% |
March 08, 2024 | 31.13% |
March 07, 2024 | 36.49% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-49.71%
Minimum
Jun 22 2022
212.5%
Maximum
Apr 08 2021
2.83%
Average
-5.00%
Median
Feb 08 2024
1 Year Total Returns (Daily) Benchmarks
Morphic Holding Inc | -41.32% |
NovaBay Pharmaceuticals Inc | -83.33% |
Palatin Technologies Inc | -20.93% |
iBio Inc | -90.27% |
Theriva Biologics Inc | -48.06% |